RXST RxSight Inc
Price (delayed)
$26.12
Market cap
$1.06B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.71
Enterprise value
$1.05B
Highlights
RXST's gross profit has soared by 84% YoY and by 13% from the previous quarter
RXST's equity has surged by 75% year-on-year
RxSight's quick ratio has increased by 46% YoY but it has decreased by 11% from the previous quarter
RxSight's debt has increased by 9% from the previous quarter
Key stats
What are the main financial stats of RXST
Market
Valuations
Earnings
Shares outstanding
40.49M
Market cap
$1.06B
Enterprise value
$1.05B
Price to earnings (P/E)
N/A
Price to book (P/B)
3.74
Price to sales (P/S)
7.26
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
7.52
Revenue
$139.93M
Gross profit
$98.94M
Operating income
-$36.86M
Net income
-$27.46M
EBIT
-$27.38M
EBITDA
-$23.76M
Free cash flow
-$22.39M
Per share
Balance sheet
Liquidity
EPS
-$0.71
EPS diluted
-$0.71
Free cash flow per share
-$0.58
Book value per share
$6.98
Revenue per share
$3.6
TBVPS
$8.2
Total assets
$318.56M
Total liabilities
$37.33M
Debt
$12.3M
Equity
$281.24M
Working capital
$267.95M
Debt to equity
0.04
Current ratio
11.36
Quick ratio
10.36
Net debt/EBITDA
0.22
Margins
Efficiency
Dividend
EBITDA margin
-17%
Gross margin
70.7%
Net margin
-19.6%
Operating margin
-26.3%
Return on assets
-9.8%
Return on equity
-11%
Return on invested capital
-11.2%
Return on capital employed
-9.4%
Return on sales
-19.6%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
RXST stock price
How has the RxSight stock price performed over time
Intraday
3.57%
1 week
7.18%
1 month
-7.9%
1 year
-48.2%
YTD
-24.03%
QTD
3.45%
Financial performance
How have RxSight's revenue and profit performed over time
Revenue
$139.93M
Gross profit
$98.94M
Operating income
-$36.86M
Net income
-$27.46M
Gross margin
70.7%
Net margin
-19.6%
RXST's gross profit has soared by 84% YoY and by 13% from the previous quarter
RxSight's net margin has soared by 64% YoY and by 18% from the previous quarter
RXST's revenue has surged by 57% year-on-year and by 9% since the previous quarter
The company's operating margin has surged by 53% YoY and by 14% QoQ
Growth
What is RxSight's growth rate over time
Valuation
What is RxSight stock price valuation
P/E
N/A
P/B
3.74
P/S
7.26
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
7.52
The EPS has grown by 50% year-on-year and by 13% since the previous quarter
RXST's equity has surged by 75% year-on-year
RXST's P/B is 54% below its last 4 quarters average of 7.9
RXST's revenue has surged by 57% year-on-year and by 9% since the previous quarter
RXST's P/S is 56% below its last 4 quarters average of 15.9
Efficiency
How efficient is RxSight business performance
RXST's ROE has soared by 65% YoY and by 21% QoQ
The ROA has soared by 62% YoY and by 22% from the previous quarter
The return on sales has surged by 61% year-on-year and by 18% since the previous quarter
RxSight's return on invested capital has surged by 55% YoY and by 23% QoQ
Dividends
What is RXST's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for RXST.
Financial health
How did RxSight financials performed over time
The total assets has surged by 75% year-on-year and by 2.6% since the previous quarter
The company's total liabilities has surged by 68% YoY and by 12% QoQ
RxSight's debt is 96% less than its equity
RXST's debt to equity has surged by 100% year-on-year
RXST's equity has surged by 75% year-on-year
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.